August 29 2024 | Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners
BioProcess360 Partners launch dedicated Life Sciences investment fund to grow emerging bioprocessing tools and technologies.
BioProcess360 parent company, Rabbit Run Partners, contributes to Series A Funding Round for Parhelia Biosciences.
